Pralay Mukhopadhyay

Company: GlaxoSmithKline Plc

Job title: Vice President, Medicine Development Leader, Oncology R&D

Seminars:

Contextualizing the Clinical Journey of Belantamab Mafodotin as a BCMA Targeting ADC in Treatment of Relapsed or Refractory Multiple Myeloma 5:00 pm

Exploring preclinical evidence of Belantamab Mafodotin’s underlying mechanism of action in support of monotherapy development and rationale for synergy in combination Breaking down the clinical journey from statistically negative DREAMM-3 monotherapy readout to positive combination therapy data with DREAMM-7 and DREAMM-8 Explaining the regulatory vs. clinical journey to better understand strength of evidence of Belantamab…Read more

day: Day Two PM